Details for New Drug Application (NDA): 208621
✉ Email this page to a colleague
The generic ingredient in MONTELUKAST SODIUM is montelukast sodium. There are thirty-five drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the montelukast sodium profile page.
Summary for 208621
Tradename: | MONTELUKAST SODIUM |
Applicant: | Unichem |
Ingredient: | montelukast sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 208621
Mechanism of Action | Leukotriene Receptor Antagonists |
Suppliers and Packaging for NDA: 208621
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MONTELUKAST SODIUM | montelukast sodium | TABLET, CHEWABLE;ORAL | 208621 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-221 | 29300-221-10 | 1000 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (29300-221-10) |
MONTELUKAST SODIUM | montelukast sodium | TABLET, CHEWABLE;ORAL | 208621 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-221 | 29300-221-13 | 30 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (29300-221-13) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | EQ 4MG BASE | ||||
Approval Date: | Jul 2, 2018 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Jul 2, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription